RS53999B1 - Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor - Google Patents

Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Info

Publication number
RS53999B1
RS53999B1 RS20150319A RSP20150319A RS53999B1 RS 53999 B1 RS53999 B1 RS 53999B1 RS 20150319 A RS20150319 A RS 20150319A RS P20150319 A RSP20150319 A RS P20150319A RS 53999 B1 RS53999 B1 RS 53999B1
Authority
RS
Serbia
Prior art keywords
letters
thickness
front panel
sides
numbers
Prior art date
Application number
RS20150319A
Other languages
English (en)
Serbian (sr)
Inventor
Sreenivasa Reddy Mundla
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of RS53999B1 publication Critical patent/RS53999B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RS20150319A 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor RS53999B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70164105P 2005-07-22 2005-07-22
PCT/US2006/025377 WO2007018818A1 (en) 2005-07-22 2006-06-29 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor

Publications (1)

Publication Number Publication Date
RS53999B1 true RS53999B1 (sr) 2015-10-30

Family

ID=37450942

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150319A RS53999B1 (sr) 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Country Status (16)

Country Link
US (1) US7872020B2 (enExample)
EP (1) EP1910370B1 (enExample)
JP (1) JP5242391B2 (enExample)
BR (1) BRPI0613639A2 (enExample)
CA (1) CA2616196C (enExample)
DK (1) DK1910370T3 (enExample)
ES (1) ES2542425T3 (enExample)
HR (1) HRP20150474T1 (enExample)
HU (1) HUE025209T2 (enExample)
IL (1) IL188181A (enExample)
MX (1) MX2008001020A (enExample)
PL (1) PL1910370T3 (enExample)
PT (1) PT1910370E (enExample)
RS (1) RS53999B1 (enExample)
SI (1) SI1910370T1 (enExample)
WO (1) WO2007018818A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081810A1 (es) 2010-04-07 2012-10-24 Bayer Cropscience Ag Piridinilpirazoles biciclicos
MX369576B (es) * 2011-07-13 2019-11-13 Tiumbio Co Ltd Imidazoles 2-piridilo sustituidos como inhibidores de alk5 y/o alk4.
ES2791627T3 (es) 2012-11-12 2020-11-05 Inst Catalana Recerca Estudis Avancats Métodos y kits para el pronóstico del cáncer colorrectal
CA2905842C (en) 2013-03-14 2023-02-21 The Brigham And Women's Hospital, Inc. Compositions and methods for epithelial stem cell expansion comprising a wnt agonist and a histone deacetylase inhibitor
WO2016037016A1 (en) 2014-09-03 2016-03-10 The Brigham And Women's Hospital, Inc. Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
WO2016123573A1 (en) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
US10822337B2 (en) 2015-04-01 2020-11-03 Rigel Pharmaceuticals, Inc. TGF-β inhibitorC
EP3313420B1 (en) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
EP3390406A1 (en) 2015-12-15 2018-10-24 Bristol-Myers Squibb Company Cxcr4 receptor antagonists
US11021687B2 (en) 2016-01-08 2021-06-01 The Brigham And Women's Hospital, Inc. Production of differentiated enteroendocrine cells and insulin producing cells
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
WO2017161001A1 (en) 2016-03-15 2017-09-21 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
CN109548403A (zh) * 2016-07-07 2019-03-29 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
JP2019534266A (ja) 2016-10-14 2019-11-28 江蘇恒瑞医薬股▲ふん▼有限公司 5員ヘテロアリール環の架橋した環誘導体、その製造方法およびその医学的使用
US11066419B2 (en) 2016-12-30 2021-07-20 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using same
WO2018165979A1 (zh) * 2017-03-17 2018-09-20 杭州领业医药科技有限公司 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的晶型及其制备方法和药物组合物
US10995083B2 (en) 2017-03-21 2021-05-04 Hangzhou Solipharma Co., Ltd. Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
WO2019042383A1 (zh) * 2017-08-31 2019-03-07 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019105082A1 (zh) * 2017-11-30 2019-06-06 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019137027A1 (zh) * 2018-01-12 2019-07-18 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
EP3768267B1 (en) 2018-03-20 2025-05-14 Icahn School of Medicine at Mount Sinai Beta-carboline derivatives as dyrk1a inhibitors for the treatment of e.g. diabetes
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
CN113195707A (zh) 2018-08-17 2021-07-30 频率治疗公司 用于通过上调jag-1来生成毛细胞的组合物和方法
EP3837351A1 (en) 2018-08-17 2021-06-23 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
JP2022515652A (ja) 2018-12-31 2022-02-21 アイカーン スクール オブ メディシン アット マウント サイナイ キナーゼ阻害剤化合物及び組成物ならびに使用方法
CN115282280A (zh) * 2022-08-12 2022-11-04 中国科学技术大学 TGF-β1信号抑制剂的新用途
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
GB202309553D0 (en) 2023-06-24 2023-08-09 Ucl Business Ltd Compostions and uses thereof
WO2025034702A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Rmc-6291 for use in the treatment of ras protein-related disease or disorder
WO2025080946A2 (en) 2023-10-12 2025-04-17 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2025255438A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100861630B1 (ko) 2001-05-24 2008-10-07 일라이 릴리 앤드 캄파니 제약 제제로서의 신규 피롤 유도체
CA2506799A1 (en) * 2002-11-21 2004-06-10 Eli Lilly And Company Mixed lineage kinase modulators
UA80571C2 (en) 2002-11-22 2007-10-10 Lilly Co Eli Quinolinyl-pyrrolopyrazoles

Also Published As

Publication number Publication date
CA2616196A1 (en) 2007-02-15
CA2616196C (en) 2012-08-21
MX2008001020A (es) 2008-03-25
IL188181A0 (en) 2008-03-20
HRP20150474T1 (xx) 2015-06-05
US7872020B2 (en) 2011-01-18
IL188181A (en) 2014-05-28
PL1910370T3 (pl) 2015-09-30
BRPI0613639A2 (pt) 2012-02-22
US20100120854A1 (en) 2010-05-13
JP2009502780A (ja) 2009-01-29
ES2542425T3 (es) 2015-08-05
EP1910370B1 (en) 2015-04-22
PT1910370E (pt) 2015-06-30
DK1910370T3 (en) 2015-06-08
WO2007018818A1 (en) 2007-02-15
JP5242391B2 (ja) 2013-07-24
SI1910370T1 (sl) 2015-06-30
HUE025209T2 (en) 2016-03-29
EP1910370A1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
RS53999B1 (sr) Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor
US5760367A (en) Apparatus and method of engraving indicia on gemstones, and gemstones, produced thereby
US5536558A (en) Illuminated display using ambient natrual or artificial light
CN105814623B (zh) 表面上的发光图案
CN102275448B (zh) 高精细透光图案塑料面板的制作方法
US5419940A (en) Colorized acrylic award assembly and method of making
US5753887A (en) Apparatus for laser engraving indicia on gemstones
DE112015000587T5 (de) System und Verfahren zum Laserschneiden von Saphir unter Verwendung mehrerer Gasmedien
Dumont et al. Laser writing of 2D data matrices in glass
WO1992022226A1 (en) Simulated objects
CN203730486U (zh) 一种双面胶定位粘贴工装
GB2445129A (en) Screen printing apparatus and screen printing method
ATE154199T1 (de) Verfahren zum anbringen von gravuren auf eine oberfläche eines eiskörpers, insbesondere eines solchen aus klareis,
DE10133479C1 (de) Mit einer Kennzeichnung versehene Solarkollektorröhre und Verfahren zum Aufbringen der Kennzeichnung
MX2014011914A (es) Herramientas para elaborar articulos retrorreflectivos.
KR101814184B1 (ko) 메모리 캔들 홀더
YU49429B (sh) Postupak za izradu informacione ploče sa natpisom radnje ili firme koji treba da simulira trodimenzionalnost slova, brojeva i drugih znakova
KR20060017074A (ko) 레이저가공 장식품 및 그 제조방법
CN1144766C (zh) 紫外线激发下再现三维彩色发光图案的制备方法
CN214775131U (zh) 一种树脂光栅板
KR200397981Y1 (ko) 레이져용 금속명판
CN117577710B (zh) 一种增加彩色前板与光伏组件牢度的制作方法
JP7133695B1 (ja) 装飾体、装飾体製造装置及び装飾体製造方法
WO2009016750A1 (ja) 服飾用物品、および服飾用物品の表示部の製造方法
JP6997841B1 (ja) 装飾体、装飾体製造装置及び装飾体製造方法